<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A monoclonal diffuse histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> developed during the course of a serologically documented primary <z:e sem="disease" ids="C0149678" disease_type="Disease or Syndrome" abbrv="">Epstein-Barr virus infection</z:e> in a 22-year-old cardiac transplant recipient taking <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> and <z:chebi fb="0" ids="8382">prednisone</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>Throat washings revealed the virus at <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> presentation, and the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was shown to contain Epstein-Barr nuclear antigen-positive cells and the <z:mp ids='MP_0001799'>viral</z:mp> genome </plain></SENT>
<SENT sid="2" pm="."><plain>Prolonged inversion of the T cell helper/suppressor ratio was demonstrated </plain></SENT>
<SENT sid="3" pm="."><plain>A brief course of <z:chebi fb="4" ids="2453">acyclovir</z:chebi> appeared to halt <z:mp ids='MP_0001799'>viral</z:mp> shedding in the throat but had no apparent effect on the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
</text></document>